Published in J Periodontal Res on August 01, 2003
Mechanisms of tooth eruption and orthodontic tooth movement. J Dent Res (2008) 2.09
Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000 (2007) 1.44
The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis. Scientifica (Cairo) (2013) 1.20
Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires Toll-like receptor 2-dependent tumor necrosis factor-alpha production. Infect Immun (2007) 1.12
RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol (2007) 1.08
Periodontal disease: linking the primary inflammation to bone loss. Clin Dev Immunol (2013) 1.03
Antibody to receptor activator of NF-κB ligand ameliorates T cell-mediated periodontal bone resorption. Infect Immun (2010) 1.00
Quantitative gene expression profiling implicates genes for susceptibility and resistance to alveolar bone loss. Infect Immun (2004) 1.00
Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs. Inflammopharmacology (2013) 0.95
RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease. J Bone Miner Res (2014) 0.94
Relationship between serum RANKL and RANKL in bone. Osteoporos Int (2011) 0.94
Host response mechanisms in periodontal diseases. J Appl Oral Sci (2015) 0.90
Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss. J Immunol Res (2015) 0.89
The role of osteoimmunology in periodontal disease. Biomed Res Int (2013) 0.88
Association between postmenopausal osteoporosis and experimental periodontitis. Biomed Res Int (2014) 0.84
RANKL and OPG mRNA level after non-surgical periodontal treatment. Inflammation (2010) 0.83
Magnolol ameliorates ligature-induced periodontitis in rats and osteoclastogenesis: in vivo and in vitro study. Evid Based Complement Alternat Med (2013) 0.81
Role of polyethylene particles in peri-prosthetic osteolysis: A review. World J Orthop (2011) 0.79
Short-term clinical and osteoimmunological effects of scaling and root planing complemented by simple or repeated laser phototherapy in chronic periodontitis. Lasers Med Sci (2012) 0.79
Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health. J Periodontal Implant Sci (2013) 0.79
Non-inflammatory destructive periodontal disease: a clinical, microbiological, immunological and genetic investigation. J Appl Oral Sci (2012) 0.78
Effect of hypoxia on the expression of RANKL/OPG in human periodontal ligament cells in vitro. Int J Clin Exp Pathol (2015) 0.77
Regulation of bone lysis in inflammatory diseases. Inflammopharmacology (2003) 0.77
Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients. Dis Markers (2015) 0.76
Detection of rankl positive cells in gingival tissue in healthy & chronic periodontal disease patients-a comparative study. J Clin Diagn Res (2014) 0.76
A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis. PLoS One (2016) 0.76
Treatment of experimental periodontal disease by a selective inhibitor of cyclooxygenase-2 with scaling and root planing (SRP). Inflammopharmacology (2010) 0.75
Effect of topical application of melatonin to the gingiva on salivary osteoprotegerin, RANKL and melatonin levels in patients with diabetes and periodontal disease. Odontology (2013) 0.75
Regenerative effect of hOPG gene-modified autologous PDLs in combination with cell transplantation on periodontal defection in beagle dogs. Cytotechnology (2016) 0.75
Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery. Cent Eur J Immunol (2014) 0.75
Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcome. Arthritis Rheum (2008) 1.51
Teaching clinical skills in musculoskeletal medicine: the use of structured clinical instruction modules. J Rheumatol (2002) 1.48
Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis. Arthritis Rheum (2012) 1.29
The Jak-STAT pathway in rheumatoid arthritis. J Rheumatol (2005) 1.26
Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Arthritis Rheum (2007) 1.15
PfSPATR, a Plasmodium falciparum protein containing an altered thrombospondin type I repeat domain is expressed at several stages of the parasite life cycle and is the target of inhibitory antibodies. J Biol Chem (2003) 1.09
Apoptosis in the rheumatoid arthritis synovial membrane: modulation by disease-modifying anti-rheumatic drug treatment. Rheumatology (Oxford) (2010) 0.98
Reduced chemokine and matrix metalloproteinase expression in patients with rheumatoid arthritis achieving remission. J Rheumatol (2003) 0.97
Monitoring pesticides in the Great Barrier Reef. Mar Pollut Bull (2009) 0.96
Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium. Arthritis Res Ther (2009) 0.96
Vitamin D(2) supplementation induces the development of aortic stenosis in rabbits: interactions with endothelial function and thioredoxin-interacting protein. Eur J Pharmacol (2008) 0.94
South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome. Int J Rheum Dis (2011) 0.94
Long term monitoring of photosystem II herbicides--correlation with remotely sensed freshwater extent to monitor changes in the quality of water entering the Great Barrier Reef, Australia. Mar Pollut Bull (2011) 0.94
Only one independent genetic association with rheumatoid arthritis within the KIAA1109-TENR-IL2-IL21 locus in Caucasian sample sets: confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significance. Arthritis Res Ther (2010) 0.92
Implementation of the Water Framework Directive in European marine waters. Mar Pollut Bull (2006) 0.89
Preparation techniques for the injection of human autologous cartilage: an ex vivo feasibility study. Laryngoscope (2008) 0.88
The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints. Arthritis Res Ther (2012) 0.88
Synovial tissue analysis in clinical trials. J Rheumatol (2005) 0.88
"My foot hurts": a flare of rheumatoid arthritis? Med J Aust (2009) 0.86
TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis. Arthritis Res Ther (2011) 0.86
Indications and technique in mastoidectomy. Otolaryngol Clin North Am (2006) 0.84
Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosis. Pathology (2005) 0.84
Effects of low-dose prednisolone on hepatic and peripheral insulin sensitivity, insulin secretion, and abdominal adiposity in patients with inflammatory rheumatologic disease. Diabetes Care (2013) 0.83
Esophageal adenocarcinoma and hypertrophic osteoarthropathy with improvement following resection of esophageal cancer. J Clin Rheumatol (2011) 0.82
Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis. Arthritis Rheum (2011) 0.82
Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: quantification using color video image analysis. J Rheumatol (2003) 0.81
Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations. Br J Pharmacol (2011) 0.80
Inflammatory arthritis in a patient with primary biliary cirrhosis: B cell mediated synovitis. J Rheumatol (2010) 0.79
Warfarin and azathioprine: clinically significant drug interaction. J Rheumatol (2002) 0.79
Leflunomide for inflammatory arthritis in end-stage renal disease on peritoneal dialysis: a pharmacokinetic and pharmacogenetic study. Ann Pharmacother (2013) 0.78
Improved evidence-based management of acute musculoskeletal pain: guidelines from the National Health and Medical Research Council are now available. Med J Aust (2004) 0.78
Low dose metal particles can induce monocyte/macrophage survival. J Orthop Res (2009) 0.78
Clinical utility of telangiectasia of hands in scleroderma and other rheumatic disorders. Asian Pac J Allergy Immunol (2002) 0.78
Screening for diabetes in patients with inflammatory rheumatological disease administered long-term prednisolone: a cross-sectional study. Rheumatology (Oxford) (2012) 0.77
Stochastic processes in the causation of rheumatic disease. J Rheumatol (2002) 0.77
Spontaneous otogenic posterior fossa pneumocephalus. Otolaryngol Head Neck Surg (2010) 0.77
Expression profiling in spondyloarthropathy synovial biopsies highlights changes in expression of inflammatory genes in conjunction with tissue remodelling genes. BMC Musculoskelet Disord (2013) 0.77
Safety and acceptability of suprascapular nerve block in rheumatology patients. Clin Rheumatol (2011) 0.77
Azithromycin suppresses human osteoclast formation and activity in vitro. J Cell Physiol (2013) 0.77
Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: a phase II study. Anticancer Res (2004) 0.76
Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample sets. Ann Rheum Dis (2011) 0.76
Biologic agents-a panacea for inflammatory arthritis or not? Int J Rheumatol (2009) 0.76
Effect of Porphyromonas gingivalis on citrullination of proteins by macrophages in vitro. J Periodontol (2012) 0.76
An alternate hypothesis regarding radiologic damage to synovial tissue: comment on the editorial by Kirwan. Arthritis Rheum (2004) 0.75
ACP Journal Club. Review: Methotrexate does not increase risk for lung disease in psoriasis, psoriatic arthritis, or IBD. Ann Intern Med (2015) 0.75
Greater trochanteric pain syndrome: does imaging-identified pathology influence the outcome of interventions? Int J Rheum Dis (2013) 0.75
Evidence-based recommendations for the diagnosis of ankylosing spondylitis: results from the Australian 3E initiative in rheumatology. Med J Aust (2008) 0.75
The correlation between elevated cardiac troponin I and pulmonary artery obstruction index in ED patients with pulmonary embolism. Am J Emerg Med (2009) 0.75
Marine Pollution Bulletin Special Edition editorial. Mar Pollut Bull (2004) 0.75
A Treat-to-Target Strategy Preserves Work Capacity in a Rheumatoid Arthritis Inception Cohort Treated With Combination Conventional DMARD Therapy. J Clin Rheumatol (2017) 0.75